213 related articles for article (PubMed ID: 35573751)
1. Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma.
Gupta V; Singh V; Bajwa R; Meghal T; Sen S; Greenberg D; Anne M; Levitt MJ
J Hematol; 2022 Apr; 11(2):45-54. PubMed ID: 35573751
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin Lymphoma: A Population-Based Study.
Singh V; Gor D; Gupta V; Jacob A; Du D; Eltoukhy H; Meghal T
World J Oncol; 2022 Aug; 13(4):159-171. PubMed ID: 36128593
[TBL] [Abstract][Full Text] [Related]
4. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Am J Hematol; 2014 Mar; 89(3):310-4. PubMed ID: 24273125
[TBL] [Abstract][Full Text] [Related]
5. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
[TBL] [Abstract][Full Text] [Related]
6. Primary Thyroid Lymphoma: An Analysis of the National Cancer Database.
Vardell Noble V; Ermann DA; Griffin EK; Silberstein PT
Cureus; 2019 Feb; 11(2):e4088. PubMed ID: 31057992
[TBL] [Abstract][Full Text] [Related]
7. No difference in treatment outcome between patients with nodal versus extranodal diffuse large B-cell lymphoma.
Khan SR; Muhammad A; Soomar SM; Shoaib D; Arshad Ali A; Muhammad T; Zahir MN; Abdul Jabbar A; Abdul Rashid Y; Heger M; Moosajee MS
J Clin Transl Res; 2023 Feb; 9(1):37-49. PubMed ID: 36687299
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological spectrum of Diffuse Large B Cell lymphoma: a study targeting population yet unexplored in Pakistan.
Mahmood H; Habib M; Aslam W; Khursheed S; Fatima S; Aziz S; Habib M; Faheem M
BMC Res Notes; 2021 Sep; 14(1):354. PubMed ID: 34507605
[TBL] [Abstract][Full Text] [Related]
9. Role of local treatment in primary breast B-cell non-Hodgkin's lymphoma: a propensity score matching-based analysis from SEER database.
Zhang M; Liu N; Wang BY; Zhang J; Zhao A; Yang J; Yang J
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):22-31. PubMed ID: 35049015
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features and prognostic analysis of 151 patients with primary extra-nodal non-Hodgkin's lymphoma].
Wang C; Yuan C; He H; Bai O
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):858-62. PubMed ID: 25620485
[TBL] [Abstract][Full Text] [Related]
11. Primary breast diffuse large B-cell lymphoma: a population-based study from 1975 to 2014.
Jia Y; Sun C; Liu Z; Wang W; Zhou X
Oncotarget; 2018 Jan; 9(3):3956-3967. PubMed ID: 29423097
[TBL] [Abstract][Full Text] [Related]
12. Undertreatment of patients with localized extranodal compared with nodal diffuse large B-cell lymphoma.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Aug; 54(8):1698-705. PubMed ID: 23190406
[TBL] [Abstract][Full Text] [Related]
13. The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database.
Yin X; Xu A; Huang Z; Fan F; Wang Y; Chen L; Cui G; Hu Y; Sun C
Transl Oncol; 2021 Jul; 14(7):101106. PubMed ID: 33932917
[TBL] [Abstract][Full Text] [Related]
14. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
Skacel M; Ross CW; Hsi ED
Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China.
Shi Y; Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Liu Y; Wang S; Jin J; Gui L; Sun Y
Chin J Cancer Res; 2019 Feb; 31(1):152-161. PubMed ID: 30996573
[TBL] [Abstract][Full Text] [Related]
16. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab.
Gundrum JD; Mathiason MA; Moore DB; Go RS
J Clin Oncol; 2009 Nov; 27(31):5227-32. PubMed ID: 19770371
[TBL] [Abstract][Full Text] [Related]
17. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
[TBL] [Abstract][Full Text] [Related]
18. Primary diffuse large B-cell lymphoma of orbit: A population-based analysis.
Chen YQ; Yue ZF; Chen SN; Tong F; Yang WH; Wei RL
Front Med (Lausanne); 2022; 9():990538. PubMed ID: 36186798
[TBL] [Abstract][Full Text] [Related]
19. Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients.
Shen H; Wei Z; Zhou D; Zhang Y; Han X; Wang W; Zhang L; Yang C; Feng J
Oncol Lett; 2018 Aug; 16(2):1602-1614. PubMed ID: 30008843
[TBL] [Abstract][Full Text] [Related]
20. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]